Extract of garlic (Allium sativum) in cancer chemoprevention

Experimental Oncology

Volumn 25, Issue 2, 2003, Pages 93-97

  Ejaz, S ^b   Woong, L C ^b   Ejaz, A ^a  

^a SEMEY MEDICAL UNIVERSITY   (Kazakhstan)

^b NONE

Author keywords

Allicin; Cancer; Garlic; Organosulfur

Indexed keywords

ALLICIN; GARLIC EXTRACT; ORGANOSULFUR DERIVATIVE; SULFUR DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LIVER METABOLISM; MALE; NONHUMAN; RAT; REVIEW; TONGUE CANCER; CANCER; CANCER CHEMOTHERAPY; CELL COMPARTMENTALIZATION; CHEMOPROPHYLAXIS;

EID: 0041522647     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Linnaeus C. Species Plantarum: a facsimile of the first edition. London 1957.
2. Essman EJ. The medical uses of herbs. Fitotherapia 1984; 55: 279-89.
3. Siegers CP, Steffen B, Robke A, Pentz R. The effects of garlic preparations against human tumor cell proliferation. Phytomedicine 1999; 6: 7-11.
4. Funahashi Y, Sugi NH, Semba T, Yamamoto Y, Hamaoka S, Tsukahara-Tamai N, Ozawa Y, Tsuruoka A, Nara K, Takahashi K, Okabe T, Kamata J, Owa T, Ueda N, Haneda T, Yonaga M, Yoshimatsu K, Wakabayashi T. Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium. Cancer Res 2002; 62: 6116-23.
5. Casini A, Scozzafava A, Mastrolorenzo A, Supuran LT. Sulfonamides and sulfonylated derivatives as anticancer agents. Curr Cancer Drug Targets 2002; 2: 55-75.
6. Huang Z, Lin Z, Huang J. A novel kind of antitumour drugs using sulfonamide as parent compound. Eur J Med Chem 2001; 36: 863-72.
7. Cavallito CJ, Bailey JH. Allicin, the antibacterial principle of Allium sativum. I. Isolation, physical properties and antibacterial action. J Am Chem Soc 1944; 66: 1950-1.
8. Lawson LD. Garlic: a review of its medicinal effects and indicated active compounds. In: Phytomedicines of Europe: chemistry and biological activity. Lawson LD, Bauer R, eds. ACS Symposium Series 691; American Chemical Society: Washington, DC, 1998; pp 176-209.
9. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996; 16: 111-24.
10. Koch HP, Lawson LD. Garlic: the science and therapeutic application of Allium sativum L. and related species. 2nd ed. Williams and Wilkins, Baltimore, MD, 1996.
11. Block E. The organosulfur chemistry of the genus Allium - implications for the organic chemistry of sulfur. Angew Chem 1992; 31: 1135-78.
12. Lawson LD, Bauer R. Phytomedicines of Europe: their chemistry and biological activity. Am Chem Soc 1998; 691: 176-209.
13. Cavalitto CJ, et al. J Am Chem Soc 1944; 66: 1950.
14. Allicin. The Merck Index. Budavari S, ed. Merck and Co. Rahway: New Jersey 1989; 11th ed. p. 244.
15. Stoll A, Seebeck E. Chemical investigation on allicin, the specific principle of garlic. Adv Enzymol 1951; 11: 377-400.
16. Brodnitz MH, Pascale JV, Derslice LV. Flavor components of garlic extract. J Agr Food Chem 1971; 19: 273-5.
17. Yu T-H, Wu C-M. Stability of allicin in garlic juice. J Food Sci 1989; 54: 977-81.
18. Miron T, Rabinkov A, Mirelman D, Wilchek M, Weiner L. The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta 2000; 1463: 20-30.
19. Ankri S, Miron T, Rabinkov A, Wilchek M, Mirelman D. Allicin from garlic strongly inhibits cysteine proteinases and cytopathic effects of Entamoeba histolytica. Antimicrob Agents Chemother 1997; 41: 2286-8.
20. Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D, Weiner L. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta 1998; 1379: 233-44.
21. Miron T, Rabinkov A, Mirelman D, Weiner L, Wilchek M. A spectrophotometric assay for allicin and alliinase (alliin lyase) activity reaction of 2-nitro-5-thiobenzoate with thiosulfinates. Anal Biochem 1998; 265: 317-25.
22. Egen-Schwind C, Eckard R, Kemper FH. Metabolism of garlic constituents in the isolated perfused rat liver. Planta Med 1992; 58: 301-5.
23. Egen-Schwind C, Eckard R, Jekat FW, Wirterhoff H. Pharmacokinetics of vinyldithiins, transformation products of allicin. Planta Med 1992; 58: 8-13.
24. Freeman F, Kodera Y. Garlic chemistry: stability of s-(2-propenyl)-2-propene-1-sulfinothioate (allicin) in blood, solvents, and simulated physiological fluids. J Agric Food Chem 1995; 43: 2332-8.
25. Kodera Y. Dietary tolerance/absorption/metabolism of garlic. In: Nutraceuticals: Designer foods III garlic, soy and licorice. Paul Lanchance, ed. Trumbell, Ct: Food & Nutrition Press, 1997; 95-105.
26. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996; 16: 111-24.
27. Koch HP, Lawson LD. Garlic: the science and therapeutic application of Allium sativum L. and related species. 2nd edn. Williams and Wilkins, Baltimore, MD: 1996.
28. Block E. The organosulfur chemistry of the genus Allium - implications for the organic chemistry of sulfur. Angew Chem 1992; 31: 1135-78.
29. Chu TC, Ogidigben M, Han JC, Potter DE. Allicin-induced hypotension in rabbit eyes. J Ocul Pharmacol 1993; 9: 201-9.
30. Feldberg RS, Chang SC, Kotik AN, Nadler M, Neuwirth Z, Sundstrom DC, Thompson NH. In vitro mechanism of inhibition of bacterial cell growth by allicin. Antimicrob Agents Chemother 1988; 32: 1763-8.
31. Herbal medicine - expanded commission E monographs. Blumenthal M, Goldberg A, Brinkmann J, eds. 2000.
32. Colic M, Vucevic D, Kilibarda V, Radicevic N, Savic M. Modulatory effects of garlic extracts on proliferation of T-lymphocytes in vitro stimulated with concanavalin A. Phytomedicine 2002; 9: 117-24.
33. Colic M, Savic M. Garlic extracts stimulate proliferation of rat lymphocytes in vitro by increasing IL-2 and IL-4 production. Immunopharmacol Immunotoxicol 2000; 22: 163-81.
34. Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng J, Gridley G, Fraumeni JFJr. Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst 2002; 94: 1648-51.
35. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996; 16: 111-24.
36. Weisberger AS, Pensky J. Tumor inhibition by a sulfhydryl-blocking agent related to an active principle of garlic (Allium sativum). Cancer Res 1958; 18: 1301-8.
37. You WC, Blot WJ, Chang YS, Ershow A, Yang ZT, An Q, Henderson BE, Fraumeni JFJr, Wang TG. Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst 1989; 81: 162-4.
38. Lau BHS, Tadi PP, Tosk JM. Allium sativum (garlic) and cancer prevention. Nutr Res 1990; 10: 937-48.
39. Dion ME, Milner JA. Garlic inhibits cytochrome P450 2E1 mediated chloroxazone metabolism. FASEB J 1997; 11: A370.
40. Abdullah TH, Kandil O, Elkadi S, Carter J. Garlic revisited: therapeutic for the major diseases of our times? J Nat Med Assoc 1988; 80: 439-45.
41. Knowles LM, Milner JA. Depressed p34cdc2 kinase activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr Cancer 1997; 29: 152-6.
42. Pan XY, Li FQ, Yu RJ, Wang H. Comparison of the cytotoxic effects of fresh garlic, diallyl trisulfide, 5-fluorouracil, mitomycin and cis-DDP on two lines of gastric cancer cells. Chin J Oncol 1985; 7: 103-5.
43. Weisberger AS, Pensky J. Tumor inhibition by a sulfhydryl-blocking agent related to an active principle of garlic (Allium sativum). Cancer Res 1958; 18: 1301-8.
44. Hirsch K, Danilenko M, Giat J, Miron T, Rabinkov A, Wilchek M, Mirelman D, Levy J, Sharoni Y. Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 2000; 38: 245-54.
45. Siegers CP, Steffen B, Robke A, Pentz R. The effects of garlic preparations against human tumor cell proliferation. Phytomedicine 1999; 6: 7-11.
46. Thomson M, Ali M. Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr Cancer Drug Targets 2003; 3: 67-81.
47. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002; 113: 71S-88S.
48. Bianchini F, Vainio H. Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect 2001; 109: 893-902.
49. Milner JA. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 2001; 492: 69-81.
50. Stroll A, Seeback E. Chemical investigations of Alliin, the specific principles of garlic. Adv Enzymol 1951; 11: 377-400.
51. Cavallito CJ, Buck JS, Suter CM. Allicin, the antibacterial principle of Allium sativum. Part II. Determination of the chemical structures. J Am Chem Soc 1944; 66: 1952-4.
52. Moore GS, Atkins RD. The fungicidal and fungistatic effect of an aqueous garlic extract on medically important yeast like fungi. Mycologia 1977; 69: 341-8.
53. Belman S. Onion and garlic oils inhibit tumor promotion. Carcinogenesis 1983; 4: 1063-5.
54. Wargovich MJ. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethyl-hydrazine-induced colon cancer. Carcinogenesis 1987; 8: 487-9.
55. Munday R, Munday CM. Relative activities of organosulfur compounds derived from onions and garlic in increasing tissue activities of quinone reductase and glutathione transferase in rat tissues. Nutr Cancer 2001; 40: 205-10.
56. Balasenthil S, Ramachandran CR, Nagini S. Prevention of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis by garlic. Fitotherapia 2001; 72: 524-31.
57. Milner JA. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 2001; 492: 69-81.